Skip to main content
CDT
NASDAQ Life Sciences

Insider Andrew Regan Buys $190K in Open Market, Increases Stake to 5.4%

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
9
Price
$1.9
Mkt Cap
$10.3M
52W Low
$1.775
52W High
$1,229.7
52W Position info
7.0% above low
Off High info
100% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CDT is trading near its 52-week low of $1.775 (7.0% above the low).

Summary

Andrew Regan, CEO of Corvus Capital Ltd., made a $190,000 open market purchase of CDT Equity Inc. shares, increasing his beneficial ownership to 5.4%.


Key Events · Ownership and Investor Activity · CDT

  • Insider Open Market Purchase

    Corvus Capital Ltd., controlled by CEO Andrew Regan, purchased 100,000 shares in the open market for $190,000 on May 13, 2026.

  • Warrant Exercise

    Corvus Capital Ltd. received 147,401 shares on March 24, 2026, through a cashless exercise of pre-funded warrants, after the 1-for-25 reverse stock split.

  • Increased Beneficial Ownership

    Andrew Regan now beneficially owns 262,766 shares, representing 5.4% of the company's outstanding common stock.


Analysis · CDT · Life Sciences

This filing indicates a significant vote of confidence from Andrew Regan, CEO of Corvus Capital Ltd., who increased his beneficial ownership through a $190,000 open market purchase. This buying activity is particularly notable given the company's recent disclosures of a going concern warning and substantial share dilution events, suggesting strong conviction in the company's future despite financial challenges.

At the time of this filing, CDT was trading at $1.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.3M. The 52-week trading range was $1.78 to $1,229.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDT - Latest Insights

CDT
Jun 29, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.583
Real-time Price: $0.565 info
Change: -$0.018 (-3%) info
Market Cap: $2.832M info
CDT
Jun 26, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.680
Real-time Price: $0.565 info
Change: -$0.115 (-17%) info
Market Cap: $2.832M info
CDT
Jun 23, 2026, 6:42 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.565 info
Change: -$0.575 (-50%) info
Market Cap: $2.832M info
CDT
Jun 18, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
10
Price at Filing: $1.41
Real-time Price: $0.565 info
Change: -$0.845 (-60%) info
Market Cap: $2.832M info
CDT
Jun 16, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.7178
Real-time Price: $0.565 info
Change: -$0.1528 (-21%) info
Market Cap: $2.832M info
CDT
May 28, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.950
Real-time Price: $0.565 info
Change: -$0.385 (-41%) info
Market Cap: $2.832M info
CDT
May 28, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.950
Real-time Price: $0.565 info
Change: -$0.385 (-41%) info
Market Cap: $2.832M info
CDT
May 15, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.73
Real-time Price: $0.565 info
Change: -$1.16 (-67%) info
Market Cap: $2.832M info
CDT
May 14, 2026, 8:47 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $1.90
Real-time Price: $0.565 info
Change: -$1.34 (-70%) info
Market Cap: $2.832M info
CDT
May 06, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.09
Real-time Price: $0.565 info
Change: -$1.53 (-73%) info
Market Cap: $2.832M info